| |
|
|
|
Immunogen Inc  
|
|
5.5 0.27 (0.05%) |
10-22 16:00 |
|
Open: |
5.27 |
Pre close: |
5.23 |
Target:
|
7.01
|
|
High: |
5.53 |
Low: |
5.27 |
Resistance:
|
6.00
7.01
|
|
Volume: |
2,679,739 |
Market Cap: |
1030M |
Support:
|
4.41
3.43
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
5.48
 |
MACD |
MACD(12,26):
|
0.43 |
|
MA(20): |
4.60 |
Signal(12,26,9): |
0.35 |
|
MA(100): |
4.27 |
Stochastic Oscillator |
%K(14,3):
|
71.82  |
|
MA(250): |
4.18 |
%D(3): |
76.21 |
|
Average Volume(K) |
3-Month: |
265792
|
52-Week |
High:
|
7.07 |
|
10-Days: |
470998 |
Low: |
1.95 |
|
RSI |
RSI(14):
|
67.66 |
Change(%): |
103.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.440 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
174.54 |
|
EPS Est. Current Year |
-0.720 |
Return on Assets (ttm) |
-10.9 |
Shares Float (M) |
151.58 |
|
EPS Est. Next Year |
-1.380 |
PEG Ratio |
0.00 |
% Held by Insiders |
1.11 |
|
EPS Est. Next Quarter |
-0.240 |
Qtrly Rev. Growth |
-3.3 |
% Held by Institutions |
76.61 |
|
Forward EPS |
-0.700 |
Gross Profit (p.s.) |
-0.185 |
Shares Short (K) |
15700 |
|
Book Value (p.s.) |
-0.140 |
EBITDA (p.s.) |
-0.263 |
P/E |
-12.50 |
|
Sales Per Share |
0.495 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-39.29 |
|
Profit Margin |
-81.34 |
Operating Cash Flow
(M) |
-124.06 |
P/S |
11.10 |
|
Operating Margin |
-56.19 |
Levered Free Cash Flow
(M) |
-14.73 |
P/CF |
-7.74 |
|
|
|
|
|
|
